Reducing the risk of heart attack and stroke during COVID-19 - Click here
Too many people are still living with undetected and poorly managed high cholesterol across Cheshire and Merseyside. Public Health England (PHE) and NHS England have agreed national ambitions for the detection and management of high cholesterol and Familial Hypercholesterolaemia over the next 10 years. C&M Health and Care Partnership has committed to acheiving these ambitions through a whole-system approach.
The cholesterol ambitions are:
By 2029: 75% of eligible people aged 40 to 74 without established CVD, such as a previous heart attack or stroke, have received a formal validated CVD risk assessment and cholesterol reading recorded on a primary care data system in the last 5 years
By 2029: 45% of people aged 40 to 74 without established CVD, such as a previous heart attack or stroke, identified as having a 20% or greater 10-year risk of developing CVD in primary care are treated with statins
By 2024: 25% of people with Familial Hypercholesterolaemia (FH) are diagnosed and treated optimally according to the NICE FH Guideline
The infographic to the right reflects national levels as at 2019.
Includes guidelines, pathways, websites and other resources.Click here for more information
View on demand national and local condition-specific webinars.Click here for more information
Includes leaflets, websites, decision aids and more.Click here for more information
The evidence base driving local strategy.Click here for more information
Back to top